NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.

With more than 15 years of experience researching and developing exciting new therapies, our dedication to science has brought us to the forefront in immuno-oncology, where we are poised to change the approach to cancer treatment.

For more information, please visit http://www.newlinkgenetics.com.